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Background: Both exercise and vitamin E supplementation have been shown to reduce oxidative stress and
cardiovascular disease risk in older adults, and when combined there is evidence suggesting that they act
synergistically. The currently recommended amount of exercise for older adults is 150 min/week of moderate-
intensity exercise; however, the minimum amount of exercise necessary to achieve health benefits is not known.
The purpose of this study was to investigate the effects of 12 weeks of participation in a low-volume walking
exercise programme (i.e. 90 min/week) combined with daily vitamin E supplementation on thiobarbituric acid
reactive substances (TBARS) and oxidised low-density lipoprotein (LDL) concentrations in older adults.
Methods: The participants were recruited from the following four groups separately: 1) control (CG, n = 14), 2)
vitamin E supplementation (SG, n = 10), 3) walking (WG, n = 7), or 4) walking + supplementation (WSG, n = 7). In
the CG, participants were advised to maintain their normal lifestyle during the study. Participants in both the SG
and WSG received 450 IU (300 mg) /day of α-tocopherol for 12 weeks. The exercise programme for the WG and
WSG consisted of two 30–60 minute sessions weekly for 12 weeks (average walking time was 44.5 ± 1.6 min/
session). Blood samples were collected at baseline and at 12 weeks.
Results: Delta plasma oxidised LDL concentrations did not differ among four groups (One-factor ANOVA,
P = 0.116). However, negative delta plasma TBARS, a marker of oxidative damage, concentrations were observed in
the WG, WSG and SG relative to the CG at the end of the study period (One-factor ANOVA, P = 0.001; post hoc
tests; CG compared with WG, WSG and SG, P = 0.005; P = 0.021; P = 0.024, respectively).
Conclusion: These findings suggest that a low-volume of physical activity and/or vitamin E supplementation may
be an effective intervention strategy for reducing TBARS concentrations of older adults.
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Oxidative stress leads to vascular dysfunction and has
been implicated in the pathogenesis of aging and athero-
sclerosis [1]. The oxidative modification of low-density
lipoprotein (LDL) is a key step in the initiation and pro-
gression of atherosclerosis [2]. Uptake of oxidised LDL
by macrophages via scavenger receptors leads to lipid-
laden foam cell formation and fatty streak development
in the arterial wall [3]. In addition, oxidised LDL, oxida-
tive stress, and markers of chronic inflammation in-
crease with advancing age [4,5]. Identifying effective
strategies for preventing the oxidative modification of
LDL and oxidative stress in older adults may reduce car-
diovascular disease risk, and thus is an important public
health issue.
It has been previously reported that plasma concentra-
tions of oxidised LDL and triacylglycerol were reduced
after high intensity training (66% of heart rate reserve,
60 minutes/session, 3 times/week for 10 weeks) in older
adults [6]. However, it is important to note that it is dif-
ficult to achieve compliance when recommending high-
intensity physical activity to older adults. In addition, the
optimal amount of exercise for achieving health benefits
is still unknown, and may be lower than the currently
recommended level of 150 minutes/week of moderate-
intensity exercise [7]. To develop effective physical activ-
ity strategies to reduce cardiovascular disease risks in
older adults, it is important to further identify the effects
of lower amounts of moderate-intensity physical activity
(such as walking) on markers of cardiovascular disease
risk, including insulin, glucose and high-density lipopro-
tein (HDL)-cholesterol.
There is an inverse relationship between vitamin E in-
take and the prevalence of coronary heart disease [8,9].
In particular, α-tocopherol (an active form of vitamin E),
exhibits antioxidant and anti-inflammatory effects and
reduces the risk of atherosclerosis and cardiovascular
disease [10,11]. However, there is inconsistency in the
literature. A previous study has demonstrated that 3 years
of vitamin E supplementation (i.e. 136 IU of dl-α-tocoph-
erol (91 mg)) did not influence oxidative stress in
hypercholesterolaemic women patients [12]. Whereas an-
other previous study has indicated that 16 weeks of
moderate-intensity endurance exercise training with high
dose of vitamin E (i.e. 800 IU of dl-α-tocopherol (534 mg))
daily intake reduces lipid hydroperoxide (a marker of oxi-
dative stress) and resting blood pressure in older adults
[13]. Contrastively, a study of Bobeuf et al. investigated
that the combination of 6 month of resistance training
and antioxidant supplementation (i.e. 1000 mg of vitamin
C and 400 IU of vitamin E (267 mg)) had a positive effect
on the plasma antioxidant profile but not on the oxidative
stress in older adults [14]. These previous studies remain
unclear whether exercise programme and/or vitamin Esupplementation in the older adults has a positive effect
on the oxidative stress and oxidised LDL concentrations.
Therefore, the main purpose of this study was to
examine the effects of 12 weeks of participation in a
low-volume walking programme combined with vitamin
E supplementation on concentrations of thiobarbituric
acid reactive substances (TBARS, a marker of oxidative
damage) and oxidised LDL in older adults.
Methods
Participants
Participants aged 60–81 years were recruited from the
local communities. For the baseline evaluation, we used
a simple lifestyle-related questionnaire (physical activity,
medication, sleep, alcohol intake, and smoking). Patients
with history of cardiovascular disease, physically active
lifestyle, those who used lipid- and/or glucose-lowering
medication, were smokers, or <60 years of age were ex-
cluded from the study. A physically active lifestyle was
defined as any form of planned, structured, and repeti-
tive physical activity undertaken a minimum of 3 times
per week, lasting at least 30 min per session, for the
purpose of improving or maintaining one or more com-
ponents of physical fitness described by Butcher et al.
[15]. Consequently, none of the study participants were
trained athletes in any sporting events but some partici-
pants were recreationally active. We recruited forty-two
participants (10 males and 32 females) who initially met
the criteria for the enrollment in the present study.
From an ethical point of view, we have considered that
we should not randomly assign the participants to each
group, particularly those who do not wish to increase/
decrease their activities of daily living or receive dietary
supplements - we have recruited the participants of each
group at the same time and thus each participant knows
what they are volunteering for. Fourteen older adults
were recruited for the control group (CG). Ten older
adults were recruited for the vitamin E supplementation
group (SG). Seven older adults were recruited for the
walking group (WG). Seven older adults were recruited
for the walking and vitamin E supplementation group
(WSG). Four participants (1 male and 3 females) in the
WG could not complete the walking program of the
present study because of injury or disease (i.e. not related
to the present study). Consequently, thirty-eight partici-
pants (9 males and 29 females) were included in the ana-
lysis. Each participant was instructed not to change their
lifestyle, including dietary habits, throughout the study
period. Participants of the control group were advised to
maintain their normal lifestyle during the study. The phys-
ical characteristics of the participants are shown in Table 1.
This study was approved by the Waseda University Ethical
Advisory Committee (2011–061). Informed consent was
obtained from all participants.
Table 1 Changes in body composition at baseline and after 12 weeks
Groups P - value
WG (N = 7) WSG (N = 7) SG (N = 10) CG (N = 14) (time, interaction)
Sex, male/female Baseline 1/6 0/7 2/8 6/8 -
Age (years) Baseline 71.9 ± 1.9 65.9 ± 2.0 67.0 ± 1.8 71.9 ± 1.6 -
Height (m) Baseline 1.54 ± 0.02 1.55 ± 0.02 1.57 ± 0.02 1.57 ± 0.02 -
Body mass (kg) Baseline 53.98 ± 3.17 58.51 ± 3.27 52.56 ± 2.21 54.71 ± 2.14 0.020, 0.263
12 weeks 54.69 ± 3.28† 58.30 ± 3.40 53.07 ± 2.28† 55.41 ± 2.06
Δ +0.71 ± 0.28 −0.21 ± 0.51 +0.51 ± 0.15 +0.70 ± 0.33
BMI (kg/m2) Baseline 22.67 ± 1.02 24.42 ± 1.48 21.37 ± 0.65 22.17 ± 0.53 0.024, 0.286
12 weeks 22.95 ± 1.03 24.33 ± 1.55 21.57 ± 0.66† 22.45 ± 0.45
Δ +0.29 ± 0.12 −0.85 ± 0.21 +0.20 ± 0.56 +0.28 ± 0.14
Waist circumference (cm) Baseline 81.07 ± 3.10 84.44 ± 2.84 80.76 ± 2.50 78.84 ± 1.76 0.603, 0.194
12 weeks 84.20 ± 2.71† 82.19 ± 3.79 80.13 ± 2.10 80.39 ± 2.12
Δ +3.13 ± 1.16 −2.24 ± 2.45 −0.63 ± 2.04 +1.55 ± 1.04
SBP (mm Hg) Baseline 136.4 ± 4.2 139.7 ± 4.2 120.2 ± 3.1 135.7 ± 3.4 0.265, 0.547
12 weeks 138.4 ± 4.8 137.4 ± 3.6 124.2 ± 3.1 139.5 ± 2.0
Δ +2.0 ± 4.0 −2.3 ± 4.3 +4.0 ± 3.0 +3.8 ± 2.4
DBP (mm Hg) Baseline 78.9 ± 3.0 83.7 ± 3.8 73.2 ± 1.9 79.4 ± 2.5 0.737, 0.639
12 weeks 79.0 ± 3.8 81.0 ± 3.3 72.3 ± 1.4 81.1 ± 2.0
Δ +0.1 ± 3.0 −2.7 ± 3.4 −0.9 ± 1.5 +1.7 ± 2.2
Values are mean ± SEM. WG, walking group; WSG, walking + supplementation group; SG, supplementation group; CG, control group; BMI, body mass index; SBP,
systolic blood pressure; DBP, diastolic blood pressure.
† Significantly different from the baseline value in the same group (Paired t-test, P < 0.05).
Δ, 12 weeks – baseline difference; w, walking; ws, walking + supplementation; s, supplementation; c, control.
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All participants in the WG and WSG underwent a 12-
week, supervised exercise programme that consisted of 2
walking exercise sessions per week. Each 30–60 minute
walking session was done in the morning, between 10:00
and 11:00, and included 5 minutes of warm-up activities
and 5 minutes of cool-down activities. During weeks 1–
5, participants walked 2.6–3.5 km in 30–40 minute walk-
ing sessions. During weeks 6–12, participants completed
40–60 minute walking sessions covering distances of
3.5–4.9 km. All walking sessions were performed out-
doors and were supervised by experienced assistants.
The participants were asked to indicate their perceived
exertion during each walking session using the Borg
scale [16], and heart rate was measured using short-
range telemetry (Polar RS400, Polar Electro Oy, Finaland).
Participants in all groups were advised to maintain their
usual daily living activities during the study.Vitamin E supplementation
Participants in the SG and WSG were issued a 12-week
supply of 150 IU (100 mg) vitamin E (RRR α-tocopherol)
(Juvelux 300, Eisai Co., Ltd., Japan) capsules and
instructed to take one-capsule thrice daily (RRR α-tocopherol, 450 IU (300 mg) /day) with meals for the
entire 12 week study period.Physical activity measurement
To determine the general physical activity level of the
participants, all of the participants were asked to wear a
uniaxial accelerometer (Lifecoder-EX, Suzuken Co. Ltd.,
Nagoya, Japan) for the 12 week study period. This device
determines the level of activity intensity by measuring
the magnitude and frequency of accelerations every 4
seconds. Activity intensity is classified into one of eleven
levels (0, 0.5, 1–9), with 0 indicating the lowest and 9 in-
dicating the highest level of activity. Participants were
contacted by phone at the beginning of each week to
assess compliance and any device problems, and all
reported that there were no problems with the use of
the accelerometer. Our data analysis confirmed that all
participants wore the accelerometer every day during
the data collection period. Since we collected accelerom-
eter data from each group simultaneously, seasonality
was not an issue in the present study. Data from partici-
pants who had worn the accelerometer for at least 10
hours a day for at least 4 weekdays and 1 weekend day
after calculation of wear time were considered valid
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study was the time spent in moderate to vigorous physical
activity (MVPA). The number of minutes spent per-
forming MVPA was calculated on a daily basis, and then
used to estimate weekly activity by taking a weighted aver-
age of daily weekday and weekend activity (i.e., weekly
MVPA = (average daily weekday MVPA × 5) + (average
daily weekend MVPA × 2)). All minutes of recording with
a total of ≥ 4 activity levels were classified as MVPA. The
activity level score of 4 was utilised as a threshold for
MVPA based on a previous calibration study [19] and
corresponded to approximately 3 metabolic equivalents.
Anthropometric and blood pressure measurements
Anthropometric variables were measured at baseline and
after 12 weeks in each group. Body mass was measured
to the nearest 0.05 kg using a digital scale (Inner Scan
50, Tanita Corporation, Tokyo, Japan). Height was mea-
sured to the nearest 0.1 cm using a wall-mounted
stadiometer (YS-OA, As One Corporation, Osaka, Japan).
Body mass index (BMI) was calculated as weight in kilo-
grams divided by the square of height in meters. Waist
circumference was measured to the nearest 0.1 cm at the
level of the umbilicus using a flexible plastic tape while
the participants were in a standing position. Arterial blood
pressure was measured using a mercury sphygmomanom-
eter (605P, Yagami Co. Ltd., Nagoya, Japan) after partici-
pants had been seated at rest for 5 minutes. For each
variable, two measurements were taken at each time point
and the mean of these values was recorded.
Dietary assessment
To examine whether dietary intake of antioxidants
influenced outcome factors, diet recall questions were
conducted at baseline and during week 10 of the study
period. Diet records were analysed using a computerised
nutritional analysis system (Excel Eiyokun, Kenpakusha,
Japan). Dietary assessments were conducted by a regis-
tered dietitian.
Blood collection and laboratory assays
Fasting venous blood samples were taken from an
antecubital vein at baseline and at 12 weeks. Participants
were asked to avoid physical activity for 48 hours, and to
fast overnight for at least 10 hours, before the blood
samples were taken. Blood concentrations of oxidised
LDL, thiobarbituric acid reactive substances (TBARS), α-
tocopherol, glucose, insulin, HbA1c, soluble E-selectin
(sE-selectin), soluble vascular cell adhesion molecule
(sVCAM-1), C-peptide, triacylglycerol, total cholesterol
(TC), HDL-cholesterol and low-density lipoprotein (LDL)-
cholesterol were measured. For α-tocopherol, triacy-
lglycerol, TC, HDL-cholesterol and LDL-cholesterol, the
blood samples were collected into tubes containingclotting activators to facilitate separation of serum. The
samples were allowed to clot for 45 minutes at room
temperature and were then centrifuged at 3000 rpm for 10
minutes at 4°C. After separation, serum was aliquoted into
plain micro tubes and stored at −80°C for later analysis.
For HbA1c, oxidised LDL, TBARS, insulin, sE-selectin,
sVCAM-1 and C-peptide, venous blood samples were col-
lected into tubes containing disodium salt-EDTA. The
samples were immediately centrifuged and the plasma
separated and aliquoted as described above. For glucose
measurements, venous blood samples were collected into
tubes containing sodium fluoride-EDTA, immediately
centrifuged, and aliquoted as described above.
Plasma concentrations of oxidised LDL (Mercodia AB,
Uppsala, Sweden), insulin (Mercodia AB, Uppsala,
Sweden), sE-selectin (eBioscience, Inc., San Diego, USA),
sVCAM-1 (eBioscience, Inc., San Diego, USA) and C-
peptide (Mercodia AB, Uppsala, Sweden) were measured
by enzyme-linked immunosorbent assay using commer-
cially available kits. Concentrations of serum triacy-
lglycerol, TC, HDL-cholesterol, LDL-cholesterol, plasma
glucose and HbA1c were determined using standard
laboratory methods. Plasma TBARS was measured using
an assay kit from Cayman Chemicals (Cayman Chemicals,
Michigan, USA). The concentration of serum α-tocopherol
was measured using high performance liquid chromatog-
raphy (HPLC) by the method of Talwar et al. [20]. Then,
serum α-tocopherol concentrations were normalised to
serum triacylglycerol and TC concentrations.
Statistical analysis
Data were analysed using Predictive Analytics Software
(PASW) version 18.0 for Windows (SPSS Japan Inc.,
Tokyo, Japan). The Shapiro-Wilk test was used to check
for normality of distribution. One-factor analysis of vari-
ance (ANOVA) was used to examine the differences in
the baseline and delta values of physical and physiological
variables, dietary and physical activity data, and blood
markers among the 4 groups. A two-factor ANOVA was
used to determine differences among groups over time for
all outcome variables. Where significant effects were
found, post hoc pair-wise comparisons were performed
using the Bonferroni method. Paired Student’s t-tests were
used to assess group differences between pre- and post-
intervention data. Statistical significance was accepted at
the 5% level. Results are presented as means ± SEM.
Results
Physical characteristics and dietary data
There were no between-group differences in physical
and physiological characteristics at baseline, with the ex-
ception of systolic blood pressure (SBP) (Table 1). One-
factor ANOVA revealed a significant baseline difference
in SBP among groups (P = 0.004). SBP was significantly
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(135.7 ± 3.4 mm Hg, P = 0.016), WG (136.4 ±4.2 mm
Hg, P = 0.045), and WSG (139.7 ± 4.2 mm Hg, P =
0.010). Within-group analyses showed that body mass
increased significantly in the SG (paired t-test, P =
0.008) and WG (paired t-test, P = 0.045) after 12 weeks
relative to their baseline values, while BMI increased
only in the SG (paired t-test, P = 0.006) and waist cir-
cumference increased only in the WG (paired t-test, P =
0.035) (Table 1). Figure 1 shows the MVPA levels mea-
sured during the 12 weeks period among the four
groups. One-factor ANOVA revealed a significant differ-
ence in MVPA measured during the 12 weeks period
among groups (P = 0.001). Post hoc tests showed that
MVPA measured during the 12 week study period was
significantly higher in the WG (225.1±19.7 min/week) and
WSG (228.2± 22.8 min/week) than in the CG (132.7±18.2
min/week) and SG (134.0± 11.3 min/week). Analysis of
dietary data revealed that dietary intake (excluding supple-
mentation) of the antioxidants vitamin C, vitamin E and
β-carotene did not differ between or within groups at
baseline or during the study.
Exercise compliance and exercise amount
The mean duration of the walking sessions was 44.5 ± 1.6
min/session. The mean heart rate and perceived exertion
during the walking sessions was 113 ± 3 beats/min and
10.6 ± 0.3 (i.e. light), respectively. This corresponded to an
exercise intensity of 48 ± 4% of heart rate reserve.
Serum α-tocopherol concentrations
Figure 2 shows the serum α-tocopherol concentrations

























Figure 1 Mean (± SEM) moderate to vigorous physical activity
(MVPA) levels in the control group (CG), vitamin E
supplementation group (SG), walking group (WG) and vitamin
E plus walking group (WSG). **Significantly different from the
between group, P ≤ 0.015.WG and WSG. At baseline, there were no differences in
serum α-tocopherol concentrations among groups. Two-
factor ANOVA revealed that there were main effects of
time (P = 0.001) and time by group interactions (P =
0.001) for serum α-tocopherol concentrations.
Plasma oxidised LDL and TBARS responses
Two-factor ANOVA revealed that there were no main
effects of time (P = 0.172) and no time by group interac-
tions (P = 0.116) for plasma oxidised LDL concentra-
tions. One-factor ANOVA revealed that changes in
plasma oxidised LDL concentrations did not differ
among groups (P = 0.116) (Figure 3). However, within-
group analysis showed that plasma oxidised LDL con-
centrations significantly increased in the CG (P= 0.019)
over the 12 week study period. For plasma TBARS con-
centrations, two-factor ANOVA revealed that there was
no main effect of time (P = 0.083), but there was a sig-
nificant time by group interaction (P = 0.007). Plasma
TBARS concentration was significantly greater at 12
weeks in the CG compared with the WG, WSG and SG
(post hoc tests; CG compared with WG, WSG and SG,
P = 0.005; P = 0.021; P = 0.024, respectively) (Figure 4).
Within-group analyses showed that plasma TBARS con-
centrations significantly decreased over the study period
only in the WG (P = 0.038), and increased only in the CG
(P = 0.042), relative to baseline values.
Biochemical and hormonal parameters
Biochemical and hormonal parameters at baseline and




















Figure 2 The serum α-tocopherol concentrations (normalised
for triacylglycerol and total cholesterol concentrations)
measured at baseline and at 12 weeks in the control group
(CG), vitamin E supplementation group (SG), walking group
(WG) and vitamin E plus walking group (WSG). Data are means ±
SEM and time-group interactions are the main influencing factors
(P = 0.001, Two-factor ANOVA). **Significantly different from the
baseline value in the same group (paired Student’s t test, P < 0.01).


















Figure 3 Delta value of plasma thiobarbituric acid reactive
substances (TBARS) measured at baseline and at 12 weeks in
the control group (CG), vitamin E supplementation group (SG),
walking group (WG) and vitamin E plus walking group (WSG).
Data are means ± SEM. Data were analysed using one-factor ANOVA
followed by a Bonferroni multiple comparisons test (P = 0.001,
One-factor ANOVA). ** Significantly different from the control group
(P ≤ 0.024).
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were main effects of time (P = 0.001) and time by group
interactions (P = 0.012). Within-group analyses showed
that serum TC concentrations were significantly in-
creased in the WG, WSG and SG (paired t-test, P =
0.004; P = 0.048; P = 0.043, respectively) after 12 weeks
relative to baseline values. Two-factor ANOVA revealed
that there were no significant time by group interactions
(P ≥ 0.060) for serum HDL-cholesterol, plasma HbA1c,
sE-selectin, sVCAM-1 and C-peptide concentrations.
Within-group analyses showed that serum HDL-



















Figure 4 Delta value of oxidised low-density lipoprotein (LDL)
concentrations measured at baseline and 12 weeks in the
control group (CG), vitamin E supplementation group (SG),
walking group (WG) and vitamin E plus walking group (WSG).
Data are means ± SEM. Data were analysed using one-factor ANOVA
followed by a Bonferroni multiple comparisons test (P = 0.116, One-
factor ANOVA). There were no significant differences among group.WG (paired t-test, P = 0.038), plasma HbA1c concentra-
tions significantly decreased in both the WSG and SG
(paired t-test, P = 0.001; P = 0.023, respectively), and
plasma glucose, sE-selectin, sVCAM-1, and C-peptide
concentrations significantly increased in the CG (paired
t-test, P = 0.045; P = 0.004; P = 0.002; P = 0.001, respect-
ively) over the 12 week study period (Table 2). No sig-
nificant changes were observed in serum triacylglycerol,
serum LDL-cholesterol and plasma insulin concentra-
tions between or within the groups.
Discussion
The main purpose of this study was to examine the
effects of 12 weeks of a low-volume walking exercise
programme (< 150 minutes/week) combined with vita-
min E supplementation on plasma TBARS and oxidised
LDL concentrations in older adults. We found that
plasma oxidised LDL concentrations did not decrease
over the study period, but lower TBARS concentrations
were observed in all intervention groups (WG, WSG,
SG) relative to the control group at the end of the study
period. These results suggest that 90 minutes of walking
per week and/or increased vitamin E intake may protect
against oxidative damage in older adults.
Oxidative stress is associated with the development of
chronic disease processes such as atherosclerosis and
cardiovascular disease [21,22]. The oxidative state is
dependent on the equilibrium between the formation of
free radicals and the action of antioxidant systems
[23,24]. However, free radicals increase with advancing
age [25]. Our results demonstrate that a low-volume
walking exercise programme decreased plasma concen-
trations of TBARS (a marker of oxidative damage). This
has important for public health implications, and deter-
mining the minimum activity level that is beneficial
could provide practical guidance to the general public
and facilitate compliance with exercise recommendations.
A number of studies have reported that the majority of
individuals in many countries engage in insufficient
amounts of physical activity and fail to meet current phys-
ical activity recommendations [26]. Although the clinical
relevance of our findings is not yet known, elevated con-
centrations of oxidative stress markers increase with aging
and are associated with an increased risk of conditions
such as cancer, cardiovascular disease and metabolic syn-
drome [27,28]. A recent prospective study demonstrated
that insufficient physical activity was related to higher
mortality rates and shorter life expectancies in both men
and women [29]. Thus, a small change in plasma TBARS
concentrations brought about by walking could have im-
portant health benefits.
We found that plasma TBARS concentrations were
lower in the SG, WG and WSG compared with the CG
at the end of the study period. Vitamin E is believed to
Table 2 Changes in blood parameters at baseline and after 12 weeks
Groups P - value
WG (N = 7) WSG (N = 7) SG (N = 10) CG (N = 14) (time, interaction)
Triacylglycerol (mg/dl) Baseline 100.9 ± 13.1 97.3 ± 11.6 85.0 ± 6.0 99.1 ± 15.0 0.109, 0.703
12 weeks 112.7 ± 15.8 106.0 ± 13.1 99.0 ± 13.6 99.1 ± 12.4
Δ +11.9 ± 15.9 +8.7 ± 8.9 +14.0 ± 1.0 −0.1 ± 7.4
TC (mg/dl) Baseline 199.1 ± 9.8 224.7 ± 13.6 201.7 ± 6.8 212.6 ± 5.7 0.001, 0.012
12 weeks 235.3 ± 10.7† 237.6 ± 11.4† 217.5 ± 7.3† 214.6 ± 7.1
Δ +36.1 ± 8.1‡ +12.9 ± 5.2 +15.8 ± 6.7 +2.1 ± 6.1
HDL-C (mg/dl) Baseline 61.6 ± 4.0 64.7 ± 7.6 56.3 ± 3.4 63.5 ± 5.35 0.081, 0.165
12 weeks 70.6 ± 6.6† 63.7 ± 7.0 59.1 ± 3.7 63.8 ± 4.15
Δ +9.0 ± 3.4 −1.0 ± 3.0 +2.8 ± 1.3 +0.3 ± 3.2
LDL-C (mg/dl) Baseline 115.0 ± 7.1 132.6 ± 11.2 119.4 ± 6.3 118.7 ± 5.4 0.004, 0.122
12 weeks 135.0 ± 9.1 140.3 ± 9.1 125.6 ± 7.6 119.4 ± 5.8
Δ +20.0 ± 8.4 +7.7 ± 5.5 +6.2 ± 5.5 +0.7 ± 3.8
Glucose (mg/dl) Baseline 96.9 ± 2.8 110.0 ± 8.4 91.1 ± 1.5 90.2 ± 1.2 0.992, 0.098
12 weeks 100.3 ± 2.9 106.1 ± 8.8 89.4 ± 2.2 92.8 ± 1.1†
Δ +3.4 ± 2.7 −3.9 ± 3.1 −1.7 ± 2.5 +2.6 ± 1.2
Insulin (pmol/L) Baseline 26.1 ± 5.4 22.6 ± 4.6 17.6 ± 3.2 22.4 ± 1.3 0.021, 0.374
12 weeks 26.5 ± 5.4 33.5 ± 8.4 24.7 ± 2.3 24.9 ± 2.1
Δ +0.3 ± 7.5 +10.9 ± 5.8 +7.1 ± 3.7 +2.6 ± 1.7
HbA1c (%) Baseline 5.37 ± 0.11 5.54 ± 0.27 5.10 ± 0.09 5.11 ± 0.10 0.001, 0.823
12 weeks 5.21 ± 0.08 5.34 ± 0.27† 5.00 ± 0.07† 4.97 ± 0.04
Δ −0.16 ± 0.06 −0.20 ± 0.02 −0.10 ± 0.04 −0.14 ± 0.08
C-peptide (pmol/L) Baseline 374.4 ± 50.9 366.9 ± 40.5 369.9 ± 31.5 360.8 ± 29.1 0.001, 0.578
12 weeks 470.1 ± 71.3 492.0 ± 99.2 427.6 ± 36.6 415.8 ± 31.0†
Δ +95.6 ± 66.1 +125.1 ± 67.9 +57.7 ± 30.8 +55.0 ± 13.1
sE-selectin (ng/ml) Baseline 41.6 ± 7.1 48.9 ± 8.7 41.1 ± 2.9 39.3 ± 3.5 0.001, 0.442
12 weeks 47.4 ± 7.1 51.3 ± 8.2 44.0 ± 2.9 46.2 ± 3.7†
Δ +5.8 ± 3.7 +2.4 ± 1.6 +2.9 ± 2.2 +6.9 ± 2.0
sVCAM-1 (ng/ml) Baseline 748.3 ± 56.8 689.6 ± 43.9 603.4 ± 24.2 692.5 ± 47.8 0.019, 0.060
12 weeks 771.8 ± 66.5 692.6 ± 45.8 610.8 ± 26.1 760.3 ± 59.0†
Δ +23.5 ± 19.1 +3.0 ± 27.2 +7.4 ± 16.3 +67.8 ± 17.5
Values are mean ± SEM. WG, walking group; WSG, walking + supplementation group; SG, supplementation group; CG, control group; TC, total cholesterol; HDL-C,
high density lipopoprotein cholesterol; LDL-C, low density lipopoprotein cholesterol; sE-selectin, soluble E-selectin; sVCAM-1, soluble vascular adhesion molecule-1.
† Significantly different from the baseline value in the same group (Paired t-test, P < 0.05).
‡ Significantly different from the CG (One-factor ANOVA with Bonferroni adjustment, P = 0.007).
Δ, 12 weeks – baseline difference; w, walking; ws, walking + supplementation; s, supplementation; c, control.
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http://www.nutritionandmetabolism.com/content/10/1/38be a beneficial for reducing oxidative stress and much
attention has been paid to whether vitamin E improves
the oxidative status in older adults [13]. Moreover, Vita-
min E, exhibits antioxidant and anti-inflammatory ef-
fects and is able to modulate immune function [30]. The
Recommended Daily Allowance for vitamin E is 15 mg
(35 μmol/L) /day, which is required to maintain normal
plasma α-tocopherol concentrations [31]. In Japan, ad-
equate intake is 7.0 and 6.5 mg/day of vitamin E for
men and women, respectively, to maintain the normal
plasma α-tocopherol concentration of 12 μmol/L(Dietary Reference Intakes for Japanese, 2010). In our
study, participants maintained their normal diet during
the intervention period, and the SG and WSG received
additional supplementation of 450 IU (300 mg) /day of
vitamin E. The Tolerable Upper Intake Level for adults
is set at 1,000 mg (2,325 μmol) /day of vitamin E; this
limit is based on the adverse effect of increased tendency
to haemorrhage when higher doses are taken [28]. How-
ever, the present study did not provide placebo tablets
for the CG and WG. Therefore, compared with the re-
sults of other placebo-controlled studies, our results
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http://www.nutritionandmetabolism.com/content/10/1/38should be interpreted with caution [13,32]. It has been
previously reported that both regular physical activity
and vitamin E supplementation are useful for reducing
lipid hydroperoxide concentrations and resting blood
pressure in older adults [13]. In this previous study, the
exercise intervention consisted of exercising at 50–75%
of the predicted maximum heart rate for a minimum of
30 min twice weekly combined with 400 IU (267 mg)
vitamin E supplementation. Our findings emphasise the
potential health benefits of low-volume walking pro-
gramme (90 minutes/week) and encouraging vitamin E
supplementation (450 IU (300 mg) /day) for older
adults. Low-volume physical activity may act similarly
to, or synergistically with, vitamin E to reduce markers
of oxidative damage in this population.
We found no significant changes in plasma oxidised
LDL concentrations in the intervention groups over the
study period. These findings are inconsistent with those
of a previous study [33], which reported that long term
(3 years) supplementation with 400 IU (267 mg) of vita-
min E daily in healthy individuals significantly reduced
circulating oxidised LDL. Whereas many studies have
reported that high dose of vitamin E are poorly effective
at decreasing levels of lipid peroxidation in humans
[34,35]. Therefore, the shorter duration of our study
might explain this difference in results [36]. Another
study previously reported that high intensity training
(66% of heart rate reserve, 60 minute/session, 3 times/
week for 10 weeks) significantly reduced plasma oxidised
LDL concentrations in older adults [6]. However, we
chose to utilise a low-volume walking exercise programme
because it is difficult to achieve compliance with high in-
tensity physical activity recommendations, particularly in
older adults. It would be of interest to examine a more
long term exercise programme and vitamin E supplemen-
tation in a similar population to see whether this influ-
ences oxidised LDL concentrations.
Previous studies have examined the combined effects of
healthy life style choices on mortality risk to assess the
additive effects of such behaviours [37,38]. It is important
to address this issue because combining physical activity
with other healthy lifestyle behaviours (such as a healthy
diet, not smoking, and only moderate alcohol consump-
tion) appears to provide greater protection from disease
than physical activity alone. In the present study, our re-
sults showed that cardiovascular disease risk markers (i.e.
plasma glucose, sE-selectin, sVCAM-1, C-peptide concen-
trations) were significantly increased in the CG after 12
weeks compared with the baseline values; but no signifi-
cant changes occurred in the WG, SG and WSG. On the
other hand, the present study found that a low-volume
walking exercise programme increases serum HDL-C con-
centrations. These observations are consistent with data
from the meta-analyses [39], indicating physically activeindividuals have significantly higher concentrations of
HDL-C compared with sedentary counterparts. Also, a
meta-analysis of previous studies has suggested that higher
training volume (i.e. duration × intensity) was necessary to
increase HDL-C [40]. Since increased circulating concen-
trations of oxidised LDL and other cardiovascular disease
risk markers observed in the CG these results may suggest
that a sedentary lifestyle lead to accelerated atherosclerotic
lesion formation. However, this is only speculation. Thus,
it would be interesting to assess whether increased or de-
creased these parameters during a long-term period influ-
ences by their sedentary lifestyle.
The present study had some limitations. First, this
study was a non-randomised trial and thus we have
recruited the participants of each group at the same
time. Thus, we could not strictly match the baseline
value among groups. Consequently, there were signifi-
cant differences in SBP among the four groups. Further-
more, the non-randomisation of participants to groups
may negatively impact the significance of the present
study due to the sample selection bias. Second, we are
not able to speculate increased concentrations of glu-
cose, sE-selectin, VCAM and C-peptide in the CG. In
addition, intra-group analyses revealed that body mass
in the S and Ex groups and BMI in the S group signifi-
cantly increased after the intervention. It is possible to
speculate that this may due in part to the dietary control
as we did not fully control the participants’ diet through-
out the study.
Conclusion
In conclusion, this study demonstrated that 12 weeks of
a low-volume walking programme (< 150 min/week)
combined with daily vitamin E supplementation did not
reduce plasma oxidised LDL concentrations and cardio-
vascular disease risk markers, but did reduce plasma
TBARS concentrations in older adults.
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